CompletedNot Applicable

Chitosan Nano-hydroxyapatite Hydrogel in Non-Surgical Treatment of Intrabony Defect

Egypt24 participantsStarted 2023-03-01

Plain-language summary

The aim of this study was to evaluate the clinical effect of Chitosan with nano-hydroxyapatite hydrogel in the treatment of periodontal intrabony defects.

Who can participate

Age range25 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age from 25 to 55 years. * Both sexes. * Patients with stage II to III periodontitis with probing pocket depths ≥ 5 mm and radiographic evidence showing infrabony defect. Exclusion Criteria: * Patients received periodontal or antibiotic therapy within the previous 6 months preceding the study. * Smokers. * Pregnant and lactating females. * Patients on medications known to affect bone turnover or with known side effects to chitosan, nano-hydroxyapatite, and collagen membrane.

What they're measuring

Gingival index

Timeframe: 6 months after treatment

Trial details

NCT IDNCT06373757

SponsorOctober 6 University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-09-01

View on ClinicalTrials.gov More Chitosan trials